In about 100 years, theoretical physicist Michio Kaku believes we’ll explore the universe as pure consciousness — traveling at the speed of light, looking at asteroids, comets, meteors, and eventually the stars. “All of this within the laws of physics,” he says.
My new article from Quartz about an annual #Longevity Peace Prize, and why it could help spread anti-aging aims far and wide across the planet:
Lead transhumanist Zoltan Istvan believes creating a major prize can help solve the problem of accessibility to developing longevity sciences.
Researchers from the Beijing Institute of Brain Disorders have discovered a new method of using exosomes to deliver aptamers that prevent the accumulation of α-synuclein aggregates, which are the cause of Parkinson’s disease [1].
α-Synuclein Aggregates
Like Alzheimer’s, Parkinson’s disease is characterized by protein aggregation caused by a loss of proteostasis, one of the hallmarks of aging. In order for the brain to function properly, non-aggregated α-synuclein proteins are needed in order to facilitate the release of dopamine, a neurotransmitter, in nerve cell synapses. α-synuclein only becomes a problem when proteostasis fails and the proteins misfold, aggregate, and accumulate.
At a certain point in our lives all of us develop a negative relationship with the mirror on the wall. It just keeps showing too many lines, too many grey hairs and sagging stuff everywhere.
I know quite a few people who end up refusing to face the mirror for any reason whatever!
But we don’t all have to resort to such drastic measures, because there is something simple and enjoyable you can do to slow down the clock.
1. The 4 main things happening in Hyperbaric oxygen treatment: 1.- A decrease of inflammation 2.- An increase in the amount of oxygen in circulation and reversing hypoxia. 3.- Stimulate the release of stem cells from the brain along with the bone-derived stem cells. 4.- Kill infection. Why it matters for regenerative and dementia treatment? Listen to Dr. Scott Sherr explaining in detail in http://www.mendelhaim.com/podcast/2. For more information on Dr. Scott’s work go to https://www.hyperbaricmedicalsolutions.com/integrative-hbot/scott-sherr.
2. Raising money for academic research is a hard point, according to all of my guests, but even when we talk about Hyperbaric treatment there is a lack of money and the number of chambers declines in u.s. In Israel by the way, the demand is increasing and it takes a few months waiting in lines to start getting the treatment, this can turn into a big business opportunity in my opinion as to the risk for such research on participants is not as big as other medical research.
3. Longevity investment is a relatively new field and is lack of a method to invest by, the Three criteria that Sergey Young from the Longevity Vision Fund examine before investing in new companies are 1- will the product be affordable to touch millions of people’s lives and not only help the rich. 2- Looking for sectors that enjoy the technological exponential development paste such as AI, early diagnostics, stem cells, warbles, and organ transplants. 3 — Network, if you are a new startup and trying to raise from The Longevity vision fund, question yourself before, Do you have partners that can market your product such as big pharma or health care chain or a big manufacturer, do you collaborate with the best academic institutes in the longevity research. Go listen to the full episode Mission Alpha with Sergey Young on http://www.mendelhaim.com/podcast/3
Click on photo to start video.
Want to live a healthier, longer life? Try taking more prebiotics — also, don’t eat sometimes.
In this video, bestselling author Dave Asprey explains.
The field of cryonics — freezing the body after death to be revived in the future — is advancing with new technology and research. Now, the leading players in cryonics are gathering in South Florida to build interest and share new developments.
New research from the USC Viterbi School of Engineering could be key to our understanding of how the aging process works. The findings potentially pave the way for better cancer treatments and revolutionary new drugs that could vastly improve human health in the twilight years.
The work, from Assistant Professor of Chemical Engineering and Materials Science Nick Graham and his team in collaboration with Scott Fraser, Provost Professor of Biological Sciences and Biomedical Engineering, and Pin Wang, Zohrab A. Kaprielian Fellow in Engineering, was recently published in the Journal of Biological Chemistry.
“To drink from the fountain of youth, you have to figure out where the fountain of youth is, and understand what the fountain of youth is doing,” Graham said. “We’re doing the opposite; we’re trying to study the reasons cells age, so that we might be able to design treatments for better aging.”
Being forever young has long been a dream for many. Now there are new ways to slow down the aging process. Switzerland is jumping on the trend, with a growing hub of science and economic activity around staying young. Harvard Medical School’s David Sinclair says the “fountain of youth pill” could soon become a reality.
